Institutional investors hold a majority ownership of PDLI through the 96.64% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $8.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LOMBARDIA CAPITAL PARTNERS LLC Bought 1.4 Million shares of PDL BioPharma Inc
DANSKE BANK A/S (INVESTMENT MANA... Bought 531.2 Thousand shares of PDL BioPharma Inc
TFS CAPITAL LLC Bought 122.2 Thousand shares of PDL BioPharma Inc